A Catalyst for Good: How AI is Helping the Fight Against COVID-19; A Conversation with Ken Mulvany, Founder and Chairman of BenevolentAI
A Catalyst for Good: How AI is Helping the Fight Against COVID-19
A Conversation with Ken Mulvany, founder and executive chairman, BenevolentAI
Thursday, July 22, 10 a.m. EDT
Ken Mulvany is a serial entrepreneur and investor with more than 20 years of business leadership experience. Mulvany is the founder and chairman of BenevolentAI. Previously, he was founder and CEO of Proximagen, a biotech company developing medicines for central nervous system disorders, which he sold in 2012.
Mulvany is a passionate environmentalist and philanthropist. He was the chairman of the trustees of the Cure Parkinson’s Trust, and he now sits on several advisory boards including the Advisory Board for Oxford Sciences Innovations.
RSVP by Wednesday, July 21
This webinar will be recorded and a Zoom link will be sent the morning of the event.